You are here: Home » PTI Stories » National » News
Business Standard

Zydus Cadila gets USFDA nod for anti-viral drug

Press Trust of India  |  New Delhi 

Drug firm Zydus Cadila today said the US health regulator has given its nod to market Acylovir drug for injection used as an anti-viral chiefly in the treatment of herpes and AIDS.

"Zydus Cadila has received the final approval from the USFDA to market Acylovir for injection USP in strengths of 500 mg/vial and 1000 mg/vial," the company said in a filing.

Acylovir for injection USP caters to the anti-viral segment, the company said adding that it will be produced at the group's formulations manufacturing facility at Moraiya,

The company said the group has more than 120 approvals and has so far filed over 300 ANDAs (Abbreviated New Drug Application).

of were trading 1.59 per cent higher at Rs 537.25 apiece on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, June 15 2017. 12:42 IST